BETH BOLLINGER: Open Payments
NPI 1265498653 · BETHLEHEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$745 in 36 payments from 8 companies in 2025. Trend: 2023 $80 · 2024 $146 · 2025 $745
Food & beverage: $745
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $216 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $160 |
| ABBVIE INC. | 8 | $145 |
| UCB, Inc. | 3 | $94 |
| Amgen Inc. | 4 | $64 |
| LEO Pharma Inc. | 2 | $31 |
| Lilly USA, LLC | 1 | $21 |
| Galderma Laboratories, L.P. | 1 | $13 |
Products named: TREMFYA, SKYRIZI, ILUMYA, Bimzelx, OTEZLA, TALTZ, Leqselvi, Winlevi.
Industry payments across PA — which companies pay providers there.
